For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...
Live Science on MSN
Science history: 'Patient zero' catches SARS, the older cousin of COVID — Nov. 16, 2002
A person came down with an atypical form of pneumonia in November 2002, but it would be two months before anyone realized it ...
Merck & Co. Inc. is buying Cidara Therapeutics Inc. for $9.2 billion to acquire a late-stage flu candidate and also to outrace blockbuster Keytruda’s looming patent expiration. CD-388, Cidara’s lead ...
Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...
mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...
While sifting through the juvenile mammoth’s genetic materials for traces of RNA, the team made another surprising discovery: ...
Maternal SARS-CoV-2 infection is associated with an increased risk for adverse neurodevelopmental diagnoses among offspring.
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
Research published in Cell Reports Medicine reveals key biological differences that may explain why women with long Covid — ...
New research reveals that women with long COVID show distinct biological disruptions — including gut inflammation, anemia, ...
Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site ...
The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback